# Impact of Hybrid Coronary Revascularization on Antiplatelet Therapy

> **NCT02293928** · — · COMPLETED · sponsor: **Aarhus University Hospital Skejby** · enrollment: 40 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **PROCEDURE:** Hybrid coronary revascularization

## Key facts

- **NCT ID:** NCT02293928
- **Lead sponsor:** Aarhus University Hospital Skejby
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2014-11-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02293928

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02293928, "Impact of Hybrid Coronary Revascularization on Antiplatelet Therapy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02293928. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*